Abstract
The effects of arginine deprivation (–Arg) has been examined in 26 cell lines. Less than 10% of those with transformed or malignant phenotype survived for > 5 days, and many died more rapidly, notably leukaemic cells. Bivariate flow cytometry confirmed that vulnerable cell lines failed to move out of cell cycle into a quiescent state (G0), but reinitiated DNA synthesis. Many cells remained in S-phase, and/or had difficulty progressing through to G2 and M. Two tumour lines proved relatively ‘resistant’, A549 and MCF7. Although considerable cell loss occurred initially, both lines showed a ‘cell cycle freeze’, in which cells survived for > 10 days. These cells recovered their proliferative activity in +Arg medium, but behaved in the same manner to a second –Arg episode as they did to the first episode. In contrast, normal cells entered G0 and survived in –Arg medium for several weeks, with the majority of cells recovering with predictable kinetics in +Arg medium. In general, cells from a wide range of tumours and established lines die quickly in vitro following –Arg treatment, because of defective cell cycle checkpoint stringency, the efficacy of the treatment being most clearly demonstrated in co-cultures in which only the normal cells survived. The findings demonstrate a potentially simple, effective and non-genotoxic strategy for the treatment of a wide range of cancers. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ando K and Griffin JD (1995) Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Oncogene 10: 751–755
Bach SJ and Swaine D (1965) The effect of arginase on the retardation of tumour growth. Br J Cancer 19: 379–386
Brittenden J, Heys SD and Eremin O (1994) L-arginine and malignant disease: a potential therapeutic role?. Eur J Surg Oncol 20: 189–192
Daniel JC and Krishnan RS (1968) Amino acid requirements for growth of the rabbit blastocystin vitro. J Cell Physiol 70: 1550–1560
Dolbeare F, Gratzner H, Pallavicini MG and Gray JW (1983) Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 80: 5573–5577
Eagle H (1955) Nutritional needs of mammalian cells in tissue culture. Science 122: 501–504
Eagle H (1959) Amino acid metabolism in mammalian cell cultures. Science 130: 432–437
Ewen MT, Sluss HK, Sherr CJ, Matsushine H, Kato J and Livingstone DM (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487–497
Ewen ME, Oliver CJ, Sluss HK, Miller SJ and Peeper DS (1995) P53-dependent repression of CDK4 translation in TGF-β-induced G1 cell cycle arrest. Genes Dev 9: 204–217
Guo H, Lishko VK, Herrera H, Groce A, Kubota T and Hoffman RM (1993) Therapeutic tumor-specific cell cycle block induced by methionine starvationin vivo. Cancer Res 53: 5676–5679
Hanss J and Moore GE (1964) Studies of culture media for the growth of human tumor cells. Exp Cell Res 34: 242–256
Hester JE and Fee WE (1995) Effect of arginine on growth of squamous cell carcinoma in the CH3/KM mouse. Arch Otolaryngol Head Neck Surg 121: 193–196
Lamb J (1998) Molecular aspects of amino acid sensitive cell cycle control. PhD Thesis, University of Aberdeen: Aberdeen
Lamb J and Wheatley DN (1996) Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation. Brt J Cancer 74: 1359–1368
Lamb J and Wheatley DN (2000) Single amino acid (arginine) deprivation induces G1 arrest associated with inhibition of cdk4 expression. Exp Cell Res,
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63
Neff NT, Ross PA, Bartholomew JC and Bissell MJ (1977) Leucine in cultured cells. Exp Cell Res 106: 175–183
Ormerod MG, Orr RM and Peacock JH (1994) The role of apoptosis in cell killing by cisplatin; a flow cytometric study. Br J Cancer 69: 93–100
Pardee AB (1974) A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 71: 1286–1290
Pardee AB (1989) G1 events and the regulation of cell proliferation. Science 246: 603–608
Paul D and Walter S (1974) Growth control in primary fetal rat liver cells in culture. J Cell Physiol 85: 113–124
Rabinovitz M (1992) The pleiotypic response to amino acid deprivation is the result of interactions between components of the glycolysis and protein synthesis pathways. FEBS Lett 302: 113–116
Rabinovitz M (1996) Unchanged tRNA-phosphofructokinase interaction in amino acid deficiency. Amino Acids 10: 99–108
Rubin H and Xu K (1991) Epigenetic features of spontaneous transformation in the NIH 3T3 line of mouse cells. In Boundaries between promotion and progression during carcinogenesis, O Sudilovsky et al (eds), pp 301–313 Plenum Press: New York
Ryan WL and Elliott JA (1968) Fluorophenylalanine inhibition of tumors in mice on a phenylalanine-deficient diet. Arch Biochem Biophys 125: 797–801
Scott LA (1999) Arginine deprivation and tumour cell death: in vitro and in vivo studies. Ph.D.thesis, University of Aberdeen: Aberdeen
Scott LA, Lamb J and Wheatley DN (1998) Defects of cell cycle control in malignant cells causes rapid death in arginine deprivation. Mol Cell Biol Suppl 10: Abst. 1572
Storr JM and Burton AF (1974) The effects of arginine deficiency on lymphoma cells. Br J Cancer 30: 50–59
Tanaka H, Zaitsu H, Onodera K and Kimura G (1988) Influence of the deprivation of a single amino acid on cellular proliferation and survival in rat 3Y1 fibroblasts and their derivatives transformed by a wide variety of agents. J Cell Physiol 136: 421–430
Tobey RA and Ley KD (1970) Regulation of the initiation of DNA synthesis on Chinese hamster cells. 1. Production of stable, reversible G1-arrested populations in suspension culture. J Cell Biol 46: 151–157
Warrington RC (1978) Selective killing of oncogenic human cells cocultivated with normal human fibroblasts. J Natl Cancer Inst 61: 69–73
Warrington RC (1992) L-histidinol in experimental cancer chemotherapy – improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing multidrug-resistant phenotype. Biochem Cell Biol 70: 365–375
Weissfeld AS and Rouse H 1977a) Continued initiation of DNA synthesis in arginine-deprived Chinese hamster ovary cells. J Cell Biol 73: 200–205
Weissfeld AS and Rouse H 1977b) Arginine deprivation in KB cells. I. Effect on cell cycle progress. J Cell Biol 75: 881–888
Weissfeld AS and Rouse H 1977c) Arginine deprivation in KB cells. II. Characterization of the DNA synthesized during starvation. J Cell Biol 75: 889–898
Wheatley DN (1998) Dietary restriction, amino acid availability and cancer. The Cancer Journal 11: 183–189
Wheatley DN, Miseta A, Love EM, Strickland D and Harris I (1993) Effect of the immediate precursors of phenylalanine and tyrosine on growth and protein synthesis in phenylalanine- and tyrosine-deprived HeLa cells. Biochim Biophys Acta 1164: 209–214
Wheatley DN, Scott L, Lamb J and Smith S (2000) Single amino acid (arginine) restriction: growth and death of cultured HeLa and human diploid fibroblasts. Cell Physiol Biochem,
Wu G and Morris SM Jr (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336: 1–17
Yeatman TJ, Risley GL and Brunson ME (1991) Depletion of dietary arginine inhibits growth of metastatic tumor. Arch Surg 126: 1376–1382
Yen A and Pardee AB (1978) Arrested states produced by isoleucine deprivation and their relationship to the low serum produced arrested state in Swiss 3T3 cells. Exp Cell Res 114: 389–395
Yin Z and Wheatley DN (1994) Sensitivity of 3T3 cells to low serum concentration and the associated problems with serum withdrawal. Cell Biol Int 18: 39–47
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Scott, L., Lamb, J., Smith, S. et al. Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer 83, 800–810 (2000). https://doi.org/10.1054/bjoc.2000.1353
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1353
Keywords
This article is cited by
-
Arginine deiminase produced by lactic acid bacteria as a potent anti-cancer drug
Medical Oncology (2023)
-
Macro- and micro-nutrient–based multiplex stress conditions modulate in vitro tumorigenesis and aggressive behavior of breast cancer spheroids
In vitro models (2022)
-
A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients
Investigational New Drugs (2022)
-
Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment
Cancer Chemotherapy and Pharmacology (2021)
-
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma
Investigational New Drugs (2021)